Your browser doesn't support javascript.
loading
Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages.
Chen, Qi; Zhao, Hui; Yao, Xingmei; Lin, Zhijie; Li, Juan; Lin, Bizhen; Wang, Rui; Huang, Yue; Su, Yingying; Wu, Ting; Li, Changgui; Pan, Huirong; Huang, Shoujie; Zhang, Jun; Xia, Ningshao.
Affiliation
  • Chen Q; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Zhao H; National Institute for Food and Drug Control, Beijing 100050, China.
  • Yao X; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Lin Z; Xiamen Innovax Biotech Company, Xiamen, Fujian 361022, China.
  • Li J; National Institute for Food and Drug Control, Beijing 100050, China.
  • Lin B; Xiamen Innovax Biotech Company, Xiamen, Fujian 361022, China.
  • Wang R; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Huang Y; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Su Y; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Wu T; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Li C; National Institute for Food and Drug Control, Beijing 100050, China.
  • Pan H; Xiamen Innovax Biotech Company, Xiamen, Fujian 361022, China. Electronic address: huirong_pan@innovax.cn.
  • Huang S; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China. Electronic ad
  • Zhang J; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
  • Xia N; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
Vaccine ; 38(39): 6096-6102, 2020 09 03.
Article in En | MEDLINE | ID: mdl-32718817
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Middle aged Language: En Journal: Vaccine Year: 2020 Document type: Article Affiliation country: China Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Middle aged Language: En Journal: Vaccine Year: 2020 Document type: Article Affiliation country: China Country of publication: Países Bajos